全文获取类型
收费全文 | 35618篇 |
免费 | 3275篇 |
国内免费 | 5203篇 |
出版年
2024年 | 121篇 |
2023年 | 505篇 |
2022年 | 1175篇 |
2021年 | 1884篇 |
2020年 | 1366篇 |
2019年 | 1746篇 |
2018年 | 1589篇 |
2017年 | 1230篇 |
2016年 | 1665篇 |
2015年 | 2422篇 |
2014年 | 2913篇 |
2013年 | 3010篇 |
2012年 | 3630篇 |
2011年 | 3293篇 |
2010年 | 2113篇 |
2009年 | 1876篇 |
2008年 | 2104篇 |
2007年 | 1894篇 |
2006年 | 1654篇 |
2005年 | 1354篇 |
2004年 | 1105篇 |
2003年 | 1038篇 |
2002年 | 873篇 |
2001年 | 547篇 |
2000年 | 474篇 |
1999年 | 435篇 |
1998年 | 283篇 |
1997年 | 260篇 |
1996年 | 230篇 |
1995年 | 183篇 |
1994年 | 178篇 |
1993年 | 123篇 |
1992年 | 133篇 |
1991年 | 104篇 |
1990年 | 80篇 |
1989年 | 76篇 |
1988年 | 61篇 |
1987年 | 40篇 |
1986年 | 51篇 |
1985年 | 60篇 |
1984年 | 23篇 |
1983年 | 29篇 |
1982年 | 29篇 |
1981年 | 23篇 |
1980年 | 10篇 |
1979年 | 20篇 |
1978年 | 9篇 |
1974年 | 8篇 |
1973年 | 11篇 |
1971年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
Kai Lv Jinwei Wu Jian Wang Mingliang Liu Zengquan Wei Jue Cao Yexin Sun Huiyuan Guo 《Bioorganic & medicinal chemistry letters》2013,23(6):1754-1759
We report herein the synthesis of a series of 7-[3-alkoxyimino-4-(methyl)aminopiperidin-1-yl]quinolone/naphthyridone derivatives. In vitro antibacterial activity of these derivatives was evaluated against representative strains, and compared with ciprofloxacin (CPFX), levofloxacin (LVFX) and gemifloxacin (GMFX). The results reveal that all of the target compounds 19a–c and 20 have considerable Gram-positive activity, although they are generally less active than the reference drugs against the Gram-negative strains with some exceptions. Especially, novel compounds 19a2, 19a4 and 19a5 were found to show strong antibacterial activity (MICs: <0.008–0.5 μg/mL) against all of the tested 15 Gram-positive strains including MRSA, LVFX- and GMFX-resistant MRSE, and CPFX-, LVFX- and GMFX-resistant MSSA. 相似文献
992.
Lin Zhou Xuefeng Ge Jihua Liu Jiahong Zhou Shaohua Wei Fuyou Li Jian Shen 《Bioorganic & medicinal chemistry letters》2013,23(19):5317-5324
Hypocrellin A (HA), an a natural perylene quinine photosensitizers (PSs), can chelate with heavy metal ions, including Au(III) and Pt(IV), to form a 1:2 complex, which exhibits enhanced 1O2 generation quantum yield through the increased intersystem crossing efficiency mediated by internal heavy atom effect. Besides, the chelate process greatly improved the water solubility of HA. Comparative studies with HA and complexes have demonstrated that the heavy-atom effect on HA molecules enhances the efficiency of in vitro photodynamic (PDT) efficacy. 相似文献
993.
Tsutomu Akama Chen Dong Charlotte Virtucio Yvonne R. Freund Daitao Chen Matthew D. Orr Robert T. Jacobs Yong-Kang Zhang Vincent Hernandez Yang Liu Anne Wu Wei Bu Liang Liu Kurt Jarnagin Jacob J. Plattner 《Bioorganic & medicinal chemistry letters》2013,23(21):5870-5873
Structure–activity relationships of 6-(benzoylamino)benzoxaborole analogs were investigated for the inhibition of TNF-α, IL-1β, and IL-6 from lipopolysaccharide stimulated peripheral blood mononuclear cells. Compound 1q showed potent activity against all three cytokines with IC50 values between 0.19 and 0.50 μM, inhibited LPS-induced TNF-α and IL-6 elevation in mice and improved collagen-induced arthritis in mice. Compound 1q (AN4161) is considered to be a promising lead for novel anti-inflammatory agent with an excellent pharmacokinetic profile. 相似文献
994.
Lei Ding Feng Tang Wei Huang Qiu Jin Han Shen Ping Wei 《Bioorganic & medicinal chemistry letters》2013,23(20):5630-5633
A novel series of 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives targeting VEGFR-2, PDGFR-β and c-Kit kinases were designed and synthesized. The molecular design was based on the SAR features of indolin-2-ones as kinase inhibitors. SAR study of the series allowed us to identify compounds possessing more potent inhibitory activities against the three kinases than sunitinb with IC50 values in the low nanomolar range in vitro. Additionally, some compounds also showed favorable antiproliferative activities against a panel of cancer cell lines (BXPC-3, T24, BGC, HEPG2 and HT29). 相似文献
995.
Andrew M.K. Pennell James B. Aggen Subhabrata Sen Wei Chen Yuan Xu Edward Sullivan Lianfa Li Kevin Greenman Trevor Charvat Derek Hansen Daniel J. Dairaghi J.J. Kim Wright Penglie Zhang 《Bioorganic & medicinal chemistry letters》2013,23(5):1228-1231
A novel series of CCR1 antagonists based on the 1-(4-phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanone scaffold was identified by screening a compound library utilizing CCR1-expressing human THP-1 cells. SAR studies led to the discovery of the highly potent and selective CCR1 antagonist 14 (CCR1 binding IC50 = 4 nM using [125I]-CCL3 as the chemokine ligand). Compound 14 displayed promising pharmacokinetic and toxicological profiles in preclinical species. 相似文献
996.
Jian-Hua Liang Wei Lv Xiao-Li Li Kun An Mark Cushman He Wang Ying-Chun Xu 《Bioorganic & medicinal chemistry letters》2013,23(5):1387-1393
We report a series of new 9-oxime ether non-ketolides, including 3-hydroxyl, 3-O-acyl and 3-O-alkyl clarithromycin derivatives, and thiophene-containing ketolides 1b–1d. Unlike previously reported ketolide 1a, none of them is comparable to telithromycin. A molecular modeling study was performed to gain insight into the binding mode of alkylides 17–20 with bacterial rRNA and to rationalize the great disparity of their SAR. The 3-O-sidechains of 19 and 20 point to the so-called hydrophilic side of the macrolide ring, as seen in clarithromycin. In contrast, the 3-O-sidechains of 17 and 18 bend to the backside, the so-called hydrophobic side of the macrolide ring. The results clearly indicated the alkylides with improved antibacterial activity might possess a novel binding mode, which is different from clarithromycin and the alkylides with poor activity. 相似文献
997.
Peter W. Glunz Xiaojun Zhang Yan Zou Indawati Delucca Alexandra H. Nirschl Xuhong Cheng Carolyn A. Weigelt Daniel L. Cheney Anzhi Wei Rushith Anumula Joseph M. Luettgen Alan R. Rendina Mark Harpel Gang Luo Robert Knabb Pancras C. Wong Ruth R. Wexler E. Scott Priestley 《Bioorganic & medicinal chemistry letters》2013,23(18):5244-5248
Aminoisoquinoline and isoquinoline groups have successfully replaced the more basic P1 benzamidine group of an acylsulfonamide factor VIIa inhibitor. Inhibitory activity was optimized by the identification of additional hydrophobic and hydrophilic P′ binding interactions. The molecular details of these interactions were elucidated by X-ray crystallography and molecular modeling. We also show that decreasing the basicity of the P1 group results in improved oral bioavailability in this chemotype. 相似文献
998.
Zhen-Wei Wu Hai-Wei Xu Gui-Fu Dai Meng-Jiao Liu Li-Ping Zhu Jian Wu Ya-Nan Wang Feng-Juan Wu Dan Zhao Ming-Fu Gao Shan-Shan Nie Wei Han Jing-Hui Song Hong-Min Liu 《Bioorganic & medicinal chemistry letters》2013,23(23):6421-6426
In the present study, andrographolide (Andro, 1) derivatives were screened to identify potent inhibitors against tumor-cell migration and invasion, and associated structure–activity relationships were studied. Compared to 1, compounds 8a–8d exhibited more potent activities against migration in SGC-7901, PC-3, A549, HT-29 and Ec109 cell lines. Improved activities against tumor-cell migration and invasion were proved to be associated with the down-regulation of MMPs. 相似文献
999.
Wei Tian Guangqian Han Ju Zhu Jingjing Qi Qianqian Chen Juntao Zhao Canhui Zheng Ling Zhang Youjun Zhou Jiaguo Lv 《Bioorganic & medicinal chemistry letters》2013,23(14):4177-4184
A series of novel 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives were designed, synthesized, and their acrosin inhibitory activities in vitro were evaluated. The results of the acrosin inhibitory activity showed that all target compounds were more potent than control TLCK. Compounds AQ-A1, AQ-D3, AQ-D4, AQ-E4 and AQ-E5 exhibited stronger acrosin inhibitory activities than control ISO-1. Especially, compound AQ-E5 displayed the most potent acrosin inhibitory activity in all the compounds, with an IC50 of 0.01 μmol/mL. This study provided a new structural class for the development of novel acrosin inhibitory agents. 相似文献
1000.
Swati P. Mercer Anthony J. Roecker Susan Garson Duane R. Reiss C. Meacham Harrell Kathy L. Murphy Joseph G. Bruno Rodney A. Bednar Wei Lemaire Donghui Cui Tamara D. Cabalu Cuyue Tang Thomayant Prueksaritanont George D. Hartman Steven D. Young Christopher J. Winrow John J. Renger Paul J. Coleman 《Bioorganic & medicinal chemistry letters》2013,23(24):6620-6624
The orexin (or hypocretin) system has been identified as a novel target for the treatment of insomnia due to the wealth of biological and genetic data discovered over the past decade. Recently, clinical proof-of-concept was achieved for the treatment of primary insomnia using dual (OX1R/OX2R) orexin receptor antagonists. However, elucidation of the pharmacology associated with selective orexin-2 receptor antagonists (2-SORAs) has been hampered by the lack of orally bioavailable, highly selective small molecule probes. Herein, the discovery and optimization of a novel series of 2,5-diarylnicotinamides as potent and orally bioavailable orexin-2 receptor selective antagonists is described. A compound from this series demonstrated potent sleep promotion when dosed orally to EEG telemetrized rats. 相似文献